Back to SC US (TTGP), LTD.

BBIO
Showing 8 of 28 quarters

Position history for SC US (TTGP), LTD.'s holdings in BRIDGEBIO PHARMA INC

SC US (TTGP), LTD. holds 1.9M shares of BBIO (BRIDGEBIO PHARMA INC), worth $138.2M as of 2026-Q1. BBIO represents 1.5% of SC US (TTGP), LTD.'s portfolio.

Current Value

$138.2M

Current Shares

1.9M

Total Value Change

+$91M

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Unchanged
1.9M
0.0%
$138.2M1.5%$64.53
0
2025-Q4
Unchanged
1.9M
0.0%
$142.3M1.0%$75.48
0
2025-Q3
Unchanged
1.9M
0.0%
$96.6M0.6%$51.96
0
2025-Q2
Unchanged
1.9M
0.0%
$80.3M0.6%$44.86
0
2025-Q1
Unchanged
1.9M
0.0%
$64.3M0.6%$35.11
0
2024-Q4
Unchanged
1.9M
0.0%
$51M0.4%$27.32
0
2024-Q3
Unchanged
1.9M
0.0%
$47.4M0.3%$24.94
0
2024-Q2
Unchanged
1.9M
0.0%
$47.1M0.4%$25.33
0

Other major holders of BBIO: VIKING GLOBAL INVESTORS LP, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used